These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 24800791)
1. New oral anticoagulants in patients with cancer: current state of evidence. Sardar P; Chatterjee S; Herzog E; Pekler G; Mushiyev S; Pastori LJ; Visco F; Aronow WS Am J Ther; 2015; 22(6):460-8. PubMed ID: 24800791 [TBL] [Abstract][Full Text] [Related]
2. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses. Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628 [TBL] [Abstract][Full Text] [Related]
3. Meta-analysis on efficacy and safety of new oral anticoagulants for venous thromboembolism prophylaxis in elderly elective postarthroplasty patients. Pathak R; Giri S; Karmacharya P; Aryal MR; Poudel DR; Ghimire S; Jehangir A; Shaikh B; Rettew A; Donato AA Blood Coagul Fibrinolysis; 2015 Dec; 26(8):934-9. PubMed ID: 26258674 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of new oral anticoagulants for extended treatment of venous thromboembolism: systematic review and meta-analyses of randomized controlled trials. Sardar P; Chatterjee S; Mukherjee D Drugs; 2013 Jul; 73(11):1171-82. PubMed ID: 23812923 [TBL] [Abstract][Full Text] [Related]
5. Treatment with dabigatran or warfarin in patients with venous thromboembolism and cancer. Schulman S; Goldhaber SZ; Kearon C; Kakkar AK; Schellong S; Eriksson H; Hantel S; Feuring M; Kreuzer J Thromb Haemost; 2015 Jul; 114(1):150-7. PubMed ID: 25739680 [TBL] [Abstract][Full Text] [Related]
6. Novel oral anticoagulants in patients with renal insufficiency: a meta-analysis of randomized trials. Sardar P; Chatterjee S; Herzog E; Nairooz R; Mukherjee D; Halperin JL Can J Cardiol; 2014 Aug; 30(8):888-97. PubMed ID: 25064581 [TBL] [Abstract][Full Text] [Related]
7. Dabigatran, rivaroxaban and apixaban for extended venous thromboembolism treatment: network meta-analysis. Alotaibi G; Alsaleh K; Wu C; Mcmurtry MS Int Angiol; 2014 Aug; 33(4):301-8. PubMed ID: 25056161 [TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy and safety of anticoagulants and aspirin for extended treatment of venous thromboembolism: A network meta-analysis. Sobieraj DM; Coleman CI; Pasupuleti V; Deshpande A; Kaw R; Hernandez AV Thromb Res; 2015 May; 135(5):888-96. PubMed ID: 25795564 [TBL] [Abstract][Full Text] [Related]
9. Editor's Choice - Severe Bleeding Risks of Direct Oral Anticoagulants in the Prevention and Treatment of Venous Thromboembolism: A Network Meta-Analysis of Randomised Controlled Trials. Chen J; Lv M; Wu S; Jiang S; Xu W; Qian J; Chen M; Fang Z; Zeng Z; Zhang J Eur J Vasc Endovasc Surg; 2022 Mar; 63(3):465-474. PubMed ID: 34973879 [TBL] [Abstract][Full Text] [Related]
10. Extended treatment with non-vitamin K antagonist oral anticoagulants versus low-molecular-weight heparins in cancer patients following venous thromboembolism. A pilot study. Stepien K; Nowak K; Zalewski J; Pac A; Undas A Vascul Pharmacol; 2019 Sep; 120():106567. PubMed ID: 31158568 [TBL] [Abstract][Full Text] [Related]
11. New oral anticoagulants in elderly adults: evidence from a meta-analysis of randomized trials. Sardar P; Chatterjee S; Chaudhari S; Lip GY J Am Geriatr Soc; 2014 May; 62(5):857-64. PubMed ID: 24786913 [TBL] [Abstract][Full Text] [Related]
12. Real-world data emulating randomized controlled trials of non-vitamin K antagonist oral anticoagulants in patients with venous thromboembolism. Yoon D; Jeong HE; Park S; You SC; Bang SM; Shin JY BMC Med; 2023 Sep; 21(1):375. PubMed ID: 37775786 [TBL] [Abstract][Full Text] [Related]
13. DOACs Versus VKAs in Older Adults Treated for Acute Venous Thromboembolism: Systematic Review and Meta-Analysis. Chaudhary R; Pagali S; Garg J; Murad MH; Wysokinski WE; McBane RD J Am Geriatr Soc; 2020 Sep; 68(9):2021-2026. PubMed ID: 32441334 [TBL] [Abstract][Full Text] [Related]
14. Non-vitamin K antagonist oral anticoagulants in venous thromboembolism patients: a meta-analysis of real-world studies. Liu ZY; Zhang HX; Ma LY; Mu GY; Xie QF; Zhou S; Wang ZN; Wang Z; Hu K; Xiang Q; Cui YM BMC Cardiovasc Disord; 2022 Mar; 22(1):105. PubMed ID: 35287588 [TBL] [Abstract][Full Text] [Related]
15. Pros and cons of new oral anticoagulants in the treatment of venous thromboembolism in patients with cancer. Verso M; Agnelli G; Prandoni P Intern Emerg Med; 2015 Sep; 10(6):651-6. PubMed ID: 25840679 [TBL] [Abstract][Full Text] [Related]
16. Safety ad efficacy of direct oral anticoagulants for extended treatment of venous thromboembolism. Imberti D; Pomero F; Benedetti R; Fenoglio L Intern Emerg Med; 2016 Oct; 11(7):895-900. PubMed ID: 27550399 [TBL] [Abstract][Full Text] [Related]
17. A Review of the Efficacy and Safety Profiles of the Novel Oral Anticoagulants in the Treatment and Prevention of Venous Thromboembolism. Coulis AA; Mackey WC Clin Ther; 2018 Dec; 40(12):2140-2167. PubMed ID: 30409498 [TBL] [Abstract][Full Text] [Related]
18. Indirect treatment comparison of new oral anticoagulants for the treatment of acute venous thromboembolism. Kang N; Sobieraj DM Thromb Res; 2014 Jun; 133(6):1145-51. PubMed ID: 24713109 [TBL] [Abstract][Full Text] [Related]
19. Approach to the new oral anticoagulants in family practice: part 1: comparing the options. Douketis J; Bell AD; Eikelboom J; Liew A Can Fam Physician; 2014 Nov; 60(11):989-95. PubMed ID: 25392438 [TBL] [Abstract][Full Text] [Related]
20. Risk of Gastrointestinal Bleeding in Patients Taking Non-Vitamin K Antagonist Oral Anticoagulants: A Systematic Review and Meta-analysis. Miller CS; Dorreen A; Martel M; Huynh T; Barkun AN Clin Gastroenterol Hepatol; 2017 Nov; 15(11):1674-1683.e3. PubMed ID: 28458008 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]